Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C9EN
|
||||
Former ID |
DIB011134
|
||||
Drug Name |
AZD5312
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 1 | [524767] | ||
Company |
Astrazeneca; isis pharmaceuticals
|
||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Modulator | ||
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.